451 LONG-TERM FOLLOW-UP OF 814 CASES WITH NON-METASTATIC RENAL CELL CARCINOMA: DEFINITION OF A SURVEILLANCE PROTOCOL BASED ON UCLA INTEGRATED STAGING SYSTEM

2007 ◽  
Vol 6 (2) ◽  
pp. 135
Author(s):  
A. Antonelli ◽  
A. Cozzoli ◽  
D. Zani ◽  
T. Zanotelli ◽  
S. Cosciani Cunico ◽  
...  
Keyword(s):  
Renal Cell Carcinoma ◽  
Cell Carcinoma ◽  
Metastatic Renal Cell Carcinoma ◽  
Renal Cell ◽  
Staging System ◽  
Long Term Follow Up ◽  
Surveillance Protocol ◽  
Definition Of

Long term follow up of 50 patients with metastatic renal cell carcinoma treated with high dose i.v. interleukin. 2

1999 ◽  
Vol 35 ◽  
pp. S358
Author(s):  
M. Libra ◽  
A. Buonadonna ◽  
A. Freschi ◽  
A. Bearz ◽  
M. Berretta ◽  
...  
Keyword(s):  
Renal Cell Carcinoma ◽  
Cell Carcinoma ◽  
Metastatic Renal Cell Carcinoma ◽  
Renal Cell ◽  
Interleukin 2 ◽  
High Dose ◽  
Long Term Follow Up

scholarly journals The follow-up management of non-metastatic renal cell carcinoma: definition of a surveillance protocol

2007 ◽  
Vol 99 (2) ◽  
pp. 296-300 ◽  
Author(s):  
Alessandro Antonelli ◽  
Alberto Cozzoli ◽  
Danilo Zani ◽  
Tiziano Zanotelli ◽  
Maria Nicolai ◽  
...  
Keyword(s):  
Renal Cell Carcinoma ◽  
Cell Carcinoma ◽  
Metastatic Renal Cell Carcinoma ◽  
Renal Cell ◽  
Surveillance Protocol ◽  
Definition Of

scholarly journals Succinate Dehydrogenase–Deficient Renal Cell Carcinoma

2018 ◽  
Vol 143 (5) ◽  
pp. 643-647 ◽  
Author(s):  
Tsung-Heng Tsai ◽  
Wen-Ying Lee
Keyword(s):  
Renal Cell Carcinoma ◽  
Cell Carcinoma ◽  
Succinate Dehydrogenase ◽  
Renal Cell ◽  
World Health ◽  
Low Grade ◽  
Long Term Follow Up ◽  
Health Organization

Succinate dehydrogenase (SDH)–deficient renal cell carcinoma is a recently recognized distinct subtype of renal cell carcinoma in the 2016 World Health Organization classification. It is associated with SDH gene germline mutations, which also cause paraganglioma/pheochromocytoma, gastrointestinal stromal tumor, and pituitary adenoma. The tumor most commonly presents in young adulthood. The tumors are arranged in solid nests or in tubules and frequently show cystic change. The tumors are composed of cuboidal to oval cells with round nuclei, dispersed chromatin, and inconspicuous nucleoli. The cytoplasm is eosinophilic or flocculent but not truly oncocytic. The most distinctive histologic feature is the presence of cytoplasmic vacuoles or inclusions. Loss of SDH subunit B immunostaining is needed for a definite diagnosis. The prognosis is good for low-grade tumors but worse for tumors with high-grade nuclei, sarcomatoid change, or coagulative necrosis. Long-term follow-up is indicated.

scholarly journals Nivolumab versus everolimus in patients with advanced renal cell carcinoma: Updated results with long‐term follow‐up of the randomized, open‐label, phase 3 CheckMate 025 trial

Cancer ◽  
2020 ◽  
Vol 126 (18) ◽  
pp. 4156-4167 ◽  
Author(s):  
Robert J. Motzer ◽  
Bernard Escudier ◽  
Saby George ◽  
Hans J. Hammers ◽  
Sandhya Srinivas ◽  
...  
Keyword(s):  
Renal Cell Carcinoma ◽  
Cell Carcinoma ◽  
Renal Cell ◽  
Advanced Renal Cell Carcinoma ◽  
Open Label ◽  
Phase 3 ◽  
Open Label Phase ◽  
Long Term Follow Up

Nephron sparing surgery in von Hippel-Lindau associated renal cell carcinoma; clinicopathological long-term follow-up

2012 ◽  
Vol 11 (3) ◽  
pp. 387-394 ◽  
Author(s):  
C. A. Jilg ◽  
Hartmut P. H. Neumann ◽  
S. Gläsker ◽  
O. Schäfer ◽  
C. Leiber ◽  
...  
Keyword(s):  
Renal Cell Carcinoma ◽  
Cell Carcinoma ◽  
Renal Cell ◽  
Nephron Sparing Surgery ◽  
Von Hippel Lindau ◽  
Nephron Sparing ◽  
Long Term Follow Up
Sign in / Sign up

Export Citation Format

Share Document